While the biomarker potential of growth hormone (GH) or IGF-I in heart failure has been discussed just recently (13), the present review for the first time addresses the biomarker potential of all IGF binding proteins (IGFBPs) in cardiovascular diseases. This evidence concerns the gene GH1 and cardiovascular disorder.